Matthew Meyerson
Overview
Explore the profile of Matthew Meyerson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
368
Citations
98464
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hayes T, Aquilanti E, Persky N, Yang X, Kim E, Brenan L, et al.
Nat Commun
. 2024 Apr;
15(1):3273.
PMID: 38627431
No abstract available.
12.
Hayes T, Aquilanti E, Persky N, Yang X, Kim E, Brenan L, et al.
Nat Commun
. 2024 Mar;
15(1):2742.
PMID: 38548752
The epidermal growth factor receptor, EGFR, is frequently activated in lung cancer and glioblastoma by genomic alterations including missense mutations. The different mutation spectra in these diseases are reflected in...
13.
Singh H, Sahgal P, Kapner K, Corsello S, Gupta H, Gujrathi R, et al.
Clin Cancer Res
. 2024 Feb;
30(8):1669-1684.
PMID: 38345769
Purpose: ERBB2-amplified colorectal cancer is a distinct molecular subtype with expanding treatments. Implications of concurrent oncogenic RAS/RAF alterations are not known. Experimental Design: Dana-Farber and Foundation Medicine Inc. Colorectal cancer...
14.
Zou T, Zhou M, Gupta A, Zhuang P, Fishbein A, Wei H, et al.
Cell Rep
. 2024 Feb;
43(2):113783.
PMID: 38306275
No abstract available.
15.
Zou T, Zhou M, Gupta A, Zhuang P, Fishbein A, Wei H, et al.
Cell Rep
. 2024 Jan;
43(2):113600.
PMID: 38261514
Emerging data suggest that induction of viral mimicry responses through activation of double-stranded RNA (dsRNA) sensors in cancer cells is a promising therapeutic strategy. One approach to induce viral mimicry...
16.
Tarantino P, Gupta H, Hughes M, Files J, Strauss S, Kirkner G, et al.
Nat Commun
. 2023 Dec;
14(1):8321.
PMID: 38097580
No abstract available.
17.
Tan K, Slevin M, Leibowitz M, Garrity-Janger M, Li H, Meyerson M
bioRxiv
. 2023 Dec;
PMID: 38077026
Alterations in the structure and location of telomeres are key events in cancer genome evolution. However, previous genomic approaches, unable to span long telomeric repeat arrays, could not characterize the...
18.
Pulice J, Meyerson M
bioRxiv
. 2023 Nov;
PMID: 37994369
Amplified oncogene expression is a critical and widespread driver event in cancer, yet our understanding of how amplification-mediated elevated dosage mediates oncogenic regulation is limited. Here, we find that the...
19.
Gibson W, Sadagopan A, Shoba V, Choudhary A, Meyerson M, Schreiber S
J Am Chem Soc
. 2023 Nov;
145(48):26028-26037.
PMID: 37992275
The aberrant localization of proteins in cells is a key factor in the development of various diseases, including cancer and neurodegenerative disease. To better understand and potentially manipulate protein localization...
20.
Tarantino P, Gupta H, Hughes M, Files J, Strauss S, Kirkner G, et al.
Nat Commun
. 2023 Nov;
14(1):7496.
PMID: 37980405
The molecular underpinnings of HER2-low and HER2-0 (IHC 0) breast tumors remain poorly defined. Using genomic findings from 1039 patients with HER2-negative metastatic breast cancer undergoing next-generation sequencing from 7/2013-12/2020,...